Maravai LifeSciences Holdings, Inc.
MRVI
$3.51
$0.072.04%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -121.24M | -192.76M | -162.95M | -145.09M | -224.90M |
| Total Depreciation and Amortization | 60.27M | 58.86M | 58.02M | 56.87M | 55.32M |
| Total Amortization of Deferred Charges | 1.91M | 2.26M | 2.62M | 2.90M | 2.98M |
| Total Other Non-Cash Items | 8.19M | 111.56M | 104.91M | 104.98M | 196.29M |
| Change in Net Operating Assets | 1.43M | -1.08M | 3.95M | -12.19M | 207.00K |
| Cash from Operations | -49.44M | -21.16M | 6.54M | 7.47M | 29.89M |
| Capital Expenditure | -16.88M | -22.55M | -29.23M | -29.66M | -40.61M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -18.99M | -18.99M | -18.63M | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.65M | 1.28M | 4.66M | 5.34M | 8.32M |
| Cash from Investing | -34.22M | -40.26M | -43.20M | -24.32M | -32.29M |
| Total Debt Issued | 953.00K | 953.00K | 953.00K | 953.00K | -- |
| Total Debt Repaid | -235.14M | -235.10M | -235.06M | -235.03M | -6.04M |
| Issuance of Common Stock | 124.00K | 13.00K | -- | -- | -- |
| Repurchase of Common Stock | -5.33M | -5.35M | -5.38M | -2.08M | -1.83M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -11.47M | -2.32M | -560.00K | 443.00K | 8.81M |
| Cash from Financing | -250.87M | -241.81M | -240.05M | -235.71M | 947.00K |
| Foreign Exchange rate Adjustments | -46.00K | -38.00K | 73.00K | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -334.58M | -303.26M | -276.64M | -252.56M | -1.45M |